These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6164875)

  • 1. Elevated intranuclear dihydrotestosterone in prostatic hyperplasia of aging dogs.
    Meikle AW; Collier ES; Stringham JD; Fang SM; Taylor GN
    J Steroid Biochem; 1981 Apr; 14(4):331-5. PubMed ID: 6164875
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of testosterone, 5alpha-dihydrotestosterone and 5alpha-adrostane-3beta, 17beta-diol metabolisms in human normal and hyperplastic prostates.
    Morfin RF; Di Stefano S; Bercovici JP; Floch HH
    J Steroid Biochem; 1978 Mar; 9(3):245-52. PubMed ID: 77360
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathogenesis of prostatic hyperplasia in normal and adenomatous glands of men and dogs: 3-alpha reduction of dihydrotestesterone].
    Jacob GH
    Endokrinologie; 1977 Oct; 70(2):158-68. PubMed ID: 73458
    [No Abstract]   [Full Text] [Related]  

  • 4. Uptake, metabolism and binding of various androgens in human prostatic tissue: in vivo and in vitro studies.
    Becker H; Horst HJ; Krieg M; Steins P; Voigt KD
    J Steroid Biochem; 1975; 6(3-4):447-52. PubMed ID: 52763
    [No Abstract]   [Full Text] [Related]  

  • 5. [5 alpha-dihydrotestosterone and prostatic adenoma].
    Morfin R; Charles JF; Bercovici JP
    J Urol Nephrol (Paris); 1978; 84(10-11):691-703. PubMed ID: 84877
    [No Abstract]   [Full Text] [Related]  

  • 6. Formation of 5alpha-androstane-3alpha,17beta-diol by normal and hypertrophic human prostate.
    Jacobi GH; Wilson JD
    J Clin Endocrinol Metab; 1977 Jan; 44(1):107-15. PubMed ID: 64471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supranormal nuclear content of 5 alpha-dihydrotestosterone in benign hyperplastic prostate of humans.
    Meikle AW; Collier ES; Middleton RG; Fang SM
    J Clin Endocrinol Metab; 1980 Oct; 51(4):945-7. PubMed ID: 6158523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
    Morfin RF; Charles JF; Floch HH
    J Steroid Biochem; 1979 Jul; 11(1B):599-607. PubMed ID: 90752
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the uptake and binding of 5alpha-androstane-3alpha, 17alpha-diol by canine prostatic nuclei.
    Evans CR; Pierrepoint CG
    J Endocrinol; 1976 Jul; 70(1):31-7. PubMed ID: 932608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of endogenous testosterone, 5 alpha-dihydrotestosterone and 5 alpha-androstane-3 alpha, 17 beta-diol in subcellular fractions of the prostate, bulbocavernosus/levator ani muscle, skeletal muscle and heart muscle of the rat.
    Bartsch W; Krieg M; Voigt KD
    J Steroid Biochem; 1980 Mar; 13(3):259-64. PubMed ID: 7392604
    [No Abstract]   [Full Text] [Related]  

  • 11. Dihydrotestosterone concentration of beagle prostatic tissue: effect of age and hyperplasia.
    Ewing LL; Berry SJ; Higginbottom EG
    Endocrinology; 1983 Dec; 113(6):2004-9. PubMed ID: 6196180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrotestosterone and 3 alpha-androstanediol dynamics in the normal, involuted, and hyperplastic canine prostate.
    McKercher G; Chevalier S; Roberts KD; Bleau G; Chapdelaine A
    Steroids; 1986; 48(1-2):55-72. PubMed ID: 2444022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a specific cytosol receptor in the normal and hyperplastic canine prostate for 5alpha-androstane-3alpha, 17alpha-diol.
    Evans CR; Pierrepoint CG
    J Endocrinol; 1975 Mar; 64(3):539-48. PubMed ID: 48535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subnormal tissue 3 alpha-androstanediol and androsterone in prostatic hyperplasia.
    Meikle AW; Stringham JD; Olsen DC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):909-13. PubMed ID: 95628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen metabolism in patients with benign prostatic hypertrophy.
    Voigt KD; Horst HJ; Krieg M
    Vitam Horm; 1975; 33():417-38. PubMed ID: 59462
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone receptors in the prostate and other tissues.
    Verhoeven G; Heyns W; De Moor P
    Vitam Horm; 1975; 33():265-81. PubMed ID: 180675
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate.
    Geller J; Albert J; Lopez D; Geller S; Niwayama G
    J Clin Endocrinol Metab; 1976 Sep; 43(3):686-8. PubMed ID: 60347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of the cytosol receptors in the incorporation of androgens into the prostatic nuclei of rat.
    Nozu K; Tamaoki B
    J Steroid Biochem; 1975 Jan; 6(1):57-63. PubMed ID: 166257
    [No Abstract]   [Full Text] [Related]  

  • 20. The formation of 5alpha-androstane-3alpha, 17beta-diol by dog prostate.
    Jacobi GH; Wilson JD
    Endocrinology; 1976 Aug; 99(2):602-10. PubMed ID: 954657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.